Tag: cost-utility analyses

IS SUFFICIENT DATA AVAILABLE TO MEET HEALTH-ECONOMIC REQUIREMENTS ACROSS EUROPE?

Prague, Czech Republic – Many Central & Eastern European (CEE) countries have recently introduced mandatory health economic (HE) evaluations to grant reimbursements for medical technologies. Health economic requirements in the CEE countries are often aligned to Western European standards, mainly

Posted in Health Policy Analyses, Value in Health Regional Issues Tagged with: , , ,

Inconsistency Among Utility Values in Japanese Studies –Are All QALYs Created Equal?

Tochigi, Japan – To conduct cost–utility analyses (CUAs) for pharmaceuticals, substantial data are required. One part of these data contains the utility values used when calculating the quality-adjusted life year (QALY). Using utility data in clinical trials in Japan was uncommon;

Posted in Value in Health Regional Issues Tagged with: , , ,

Cost-Utility Analysis Of Erythropoietin For Hemodialysis Patients

Bangkok, Thailand – Most patients receiving hemodialysis (HD) for end-stage renal disease (ESRD) currently receive erythropoietin (EPO) for anemia treatment. The goal of therapy is to achieve specific hemoglobin (Hb) target levels. Higher doses of EPO are used to attain higher

Posted in Value in Health Regional Issues Tagged with: , , , ,

Challenges In Valuing The Impact Of Sexually Transmitted Infections

Birmingham, United Kingdom – Sexually transmitted infections like chlamydia are a global public health concern. Chlamydia can cause infertility and other reproductive tract problems in women. Health policy decision makers need to know which interventions they should prioritise to get the

Posted in Systematic Reviews, Value in Health Tagged with: , , , ,

Can Pharmaceutical Care Interventions Improve Type 2 Diabetes Management?

Enugu State, Nigeria – Cost-utility analysis was developed to help decision makers compare the values of alternative interventions. With the increasing demand for better management of type 2 diabetes, attention has been focused on the potential benefits of pharmaceutical care (PC)

Posted in Value in Health Regional Issues Tagged with: , , ,

Italian Social Tariffs For QALYs Calculation Are Now Available

Milano and Napoli, Italy – The Italian health care system is starting to take information on HRQoL and QALYs into consideration when deciding on the utilization of available resources. Although comparisons of different national value sets have demonstrated the existence of

Posted in Preference-Based Assessments, Value in Health Tagged with: , , , , , ,